Molecular Epidemiology and Genetic Diversity of Fluoroquinolone-Resistant Escherichia coli Isolates from Patients with Community-Onset Infections in 30 Chinese County Hospitals

Author:

Zhao Lina,Zhang Jing,Zheng Beiwen,Wei Zeqing,Shen Ping,Li Sujuan,Li Lanjuan,Xiao Yonghong

Abstract

The high frequency of fluoroquinolone resistance inEscherichia coliis a feature of clinical bacteriology in China, where the molecular epidemiology and genetic characteristics of this resistance in county hospitals remain unclear. A total of 590 nonduplicateE. coliisolates from 30 county hospitals located across seven Chinese regions were examined for plasmid-mediated quinolone resistance (PMQR) genes and mutations in quinolone resistance-determining regions (QRDRs). Multilocus sequence typing (MLST) and phylogenetic analysis of fluoroquinolone-resistant isolates were used to determine their genetic relatedness. The ciprofloxacin resistance rate of community-onsetE. coliwas 51.2%, and at least one PMQR gene was carried by 220 (37.3%) isolates. These includedqnr(3.7%),aac(6)-Ib-cr(19.7%),qepA(14.4%), andoqxAB(3.8%). Two noveloqxBmutants were identified and namedoqxB20andoqxB29. From 60 sequence types (STs) isolated, 5 novel STs (ST4499 to ST4503) were identified. ST1193 (7.9%) was the second most abundant ST among fluoroquinolone-resistant isolates (ST131 was the most common, with 14.6%), and this is the first report of it in China. This is also the first report of ST2115 and ST3014 isolates from human samples. Ciprofloxacin-resistantE. coliisolates fell mainly into phylogroups B2 and D. The rates of fluoroquinolone resistance and the prevalence of PMQR genes in community-onsetE. coliisolates from Chinese county hospitals were high. The wide-ranging molecular epidemiology ofE. coliisolates from scattered locations across China indicates that fluoroquinolone resistance evolved from different sources.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference29 articles.

1. Investigation and analysis on antibacterial drug use in four cities of China;Chin J Pharmacovigilance,2011

2. The indications and rational use of quinolones in the treatment of infectious diseases: a consensus;Scientific working group;Chin J Infect Chemother,2009

3. Mohnarin report of 2011: monitoring of bacterial resistance in China;Chin J Nosocomiol,2012

4. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007;National Healthcare Safety Network Team;Infect Control Hosp Epidemiol,2008

5. European Centre for Disease Prevention and Control. 2012. Surveillance report: antimicrobial resistance surveillance in Europe 2012. http://www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=963.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3